Glucose-6-phosphate dehydrogenase deficiency classification: Difference between revisions
No edit summary |
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
||
Line 1: | Line 1: | ||
{{Glucose-6-phosphate dehydrogenase deficiency}} | {{Glucose-6-phosphate dehydrogenase deficiency}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto: | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How to Edit a Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How to Edit a Page|here]] to learn about editing. |
Revision as of 14:43, 2 November 2012
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency classification On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency classification |
FDA on Glucose-6-phosphate dehydrogenase deficiency classification |
CDC on Glucose-6-phosphate dehydrogenase deficiency classification |
Glucose-6-phosphate dehydrogenase deficiency classification in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency classification |
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive hereditary disease featuring abnormally low levels of the G6PD enzyme, which plays an important role in red blood cell function. Individuals with the disease may exhibit non-immune hemolytic anemia in response to a number of causes. It is closely linked to favism, a disorder characterized by a hemolytic reaction to consumption of broad beans, with a name derived from the Italian name of the broad bean (fava). Sometimes the name, favism, is alternatively used to refer to the enzyme deficiency as a whole.
Classification
There are four forms of G6PD:
- Hereditary nonspherocytic hemolytic anemia
- Severe deficiency
- Mild deficiency
- Non-deficient variant
- Favism is a disorder characterized by hemolytic anemia in response to ingestion of fava beans. Favism as a diagnosis has been known since antiquity, perhaps in relation to Pythagoras, among others. All individuals with favism show G6PD deficiency. However, not all individuals with G6PD deficiency show favism. For example, in a small study of 757 Saudi men, more than 42% showed G6PD deficiency, but none reported symptoms of favism, despite fava in the diet.[1] Favism is known to be more prevalent in infants and children, and G6PD genetic variant can influence chemical sensitivity. Other than this, the detailed chemical relationship between favism and G6PD is not well known.
References
- ↑ "Common G6PD variant from Saudi population". Retrieved 2007-10-28.